Kolexia
De Sèze Jérôme Neurologie
De Sèze Jérôme
Neurologie
Hôpital Hautepierre
Strasbourg, France
710 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Neuromyélite optique Sclérose en plaques récurrente-rémittente Névrite optique Maladies démyélinisantes Névrite COVID-19 Sclérose en plaques chronique progressive

Collaborateurs

Voir plus
Collongues Nicolas
Collongues Nicolas
Hôpital Civil, Strasbourg, France
Labauge Pierre
Labauge Pierre
Hôpital Gui de Chauliac, Montpellier, France
Frenay Christine
Frenay Christine
Hôpital Pasteur, Nice, France
Vukusic Sandra
Vukusic Sandra
Hôpital Pierre Wertheimer, Bron, France

Industries

Voir plus
Novartis
134 collaboration(s)
Dernière en 2023
Biogen
68 collaboration(s)
Dernière en 2023
Roche
51 collaboration(s)
Dernière en 2023
Janssen
47 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Essai Clinique (Roche)   07 mars 2024
In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO: IMCY-NMO-000 In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized Neuromyelitis Optica (PHASE 0)
Essai Clinique (Imcyse SA)   06 mars 2024
Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study.
Multiple sclerosis journal - experimental, translational and clinical   29 février 2024
OPTIS: Performance and Safety of a Digital Tool for Unsupervised Self-assessment of Neuromyelitis Optica Spectrum Disorder
Essai Clinique (Ad scientiam)   27 février 2024
VHD cohort: Very High Definition Cohort: Assessment of New Prognostic Biomarkers of Disability Worsening in a Multicenter Cohort of MS Patients by Imaging, Optical Coherence Tomography and Biology
Essai Clinique (EDMUS Foundation)   15 février 2024
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif®) in Patients With Relapsing Multiple Sclerosis
Essai Clinique (Roche)   13 février 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA neurology   12 février 2024
RESPONSE: French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Essai Clinique (Hospices Civils de Lyon)   25 janvier 2024
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study.
Frontiers in neurology   22 janvier 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Multiple sclerosis (Houndmills, Basingstoke, England)   21 janvier 2024